Inventor · disambiguated record
Terry B. Strom
Also filed as: STROM TERRY · STROM TERRY B · STROM TERRY BARTON
35 granted patents·24 pending applications·1,050 citations·filing 1985–2018
98Inventor score
Files withBETH ISRAEL HOSPITAL29BRIGHAM & WOMENS HOSPITAL6STROM TERRY B4BETH ISRAEL DEACONESS MEDICAL CT INC3CORNELL RES FOUNDATION INC3
Top patents by PatentIndex Score
59 records- 0195US7834152B2Antagonists of interleukin-15BETH ISRAEL HOSPITAL·Filed 2007·Granted Nov 16, 2010·22 cites·20 claims
- 0293US7258853B2Antagonists of interleukin-15BETH ISRAEL HOSPITAL·Filed 2002·Granted Aug 21, 2007·28 cites·29 claims
- 0393US6998476B2Nucleic acids encoding antagonists of interleukin-15BETH ISRAEL HOSPITAL·Filed 2002·Granted Feb 14, 2006·33 cites·26 claims
- 0492US6165476AFusion proteins with an immunoglobulin hinge region linkerBETH ISRAEL HOSPITAL·Filed 1997·Granted Dec 26, 2000·117 cites·20 claims
- 0590US6770272B2Treatment of diabetesBETH ISRAEL HOSPITAL·Filed 2002·Granted Aug 3, 2004·24 cites·9 claims
- 0688US5958403AMethods and compounds for prevention of graft rejectionBETH ISRAEL HOSPITAL·Filed 1994·Granted Sep 28, 1999·74 cites·1 claims
- 0787US6797263B2Compositions and methods for achieving immune suppressionBETH ISRAEL HOSPITAL·Filed 2001·Granted Sep 28, 2004·33 cites·20 claims
- 0887US6451308B1Antagonists of interleukin-15BETH ISRAEL HOSPITAL·Filed 1999·Granted Sep 17, 2002·54 cites·11 claims
- 0987US6403077B1Treatment regimes featuring an IL-10-containing chimeric polypeptideBETH ISRAEL HOSPITAL·Filed 1997·Granted Jun 11, 2002·89 cites·6 claims
- 1086US8329660B2Tim-3 ligands and methods thereofKUCHROO VIJAY K·Filed 2004·Granted Dec 11, 2012·33 cites·8 claims
- 1186US6410008B1Chimeric IL-10 proteins and uses thereofBETH ISRAEL HOSPITAL·Filed 1994·Granted Jun 25, 2002·48 cites·7 claims
- 1286US6001973AAntagonists of interleukin-15BETH ISRAEL HOSPITAL·Filed 1997·Granted Dec 14, 1999·69 cites·9 claims
- 1384US7347995B2Compositions and methods for achieving immune suppressionBETH ISRAEL HOSPITAL·Filed 2004·Granted Mar 25, 2008·22 cites·17 claims
- 1484US5510105ATreatment of autoimmune diseases with IL-2 receptor-specific cytotoxinsBETH ISRAEL HOSPITAL·Filed 1994·Granted Apr 23, 1996·30 cites·11 claims
- 1583US5011684ALysing or blocking unwanted cells with IL-2 receptor-specific binding substanceBETH ISRAEL HOSPITAL·Filed 1985·Granted Apr 30, 1991·39 cites·6 claims
- 1682US7741271B2Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2005·Granted Jun 22, 2010·6 cites·12 claims
- 1782US7579439B2Modulation of IL-2- and IL-15-mediated T cell responsesBETH ISRAEL HOSPITAL·Filed 2003·Granted Aug 25, 2009·16 cites·10 claims
- 1882US6900015B2Measurement of protective genes in allograft rejectionCORNELL RES FOUNDATION INC·Filed 2001·Granted May 31, 2005·42 cites·17 claims
- 1981US5336489ATreatment of allograft rejection with IL-2 receptor-specific cytotoxinsBETH ISRAEL HOSPITAL·Filed 1992·Granted Aug 9, 1994·26 cites·6 claims
- 2079US5674494ATreating non-malignant disease states with IL-2 receptor-specific substancesBETH ISRAEL HOSPITAL·Filed 1995·Granted Oct 7, 1997·26 cites·32 claims
- 2176US7018626B2Chimeric IL-10BETH ISRAEL HOSPITAL·Filed 2002·Granted Mar 28, 2006·4 cites·15 claims
- 2275US9346876B2TIM-3 ligands and methods of modulating immune responsesBRIGHAM & WOMENS HOSPITAL·Filed 2014·Granted May 24, 2016·2 cites·7 claims
- 2375US5607675ATreatment of autoimmune diseases with IL-2 receptor-specific cytotoxinBETH ISRAEL HOSPITAL·Filed 1995·Granted Mar 4, 1997·21 cites·10 claims
- 2474US6187534B1Methods of evaluating transplant rejectionCORNELL RES FOUNDATION INC·Filed 1997·Granted Feb 13, 2001·59 cites·23 claims
- 2571US8623830B2Compositions containing α-1-antitrypsin and methods for useFLIER JEFFREY·Filed 2007·Granted Jan 7, 2014·4 cites·55 claims
- 2671US5152980AInduction of tolerance to a foreign antigen IL-2 receptor-binding substancesBETH ISRAEL HOSPITAL·Filed 1989·Granted Oct 6, 1992·41 cites·14 claims
- 2770US5916559AUse of interleukin-2 (IL-2) receptor-specific agents to treat allograft rejectionBETH ISRAEL HOSPITAL·Filed 1996·Granted Jun 29, 1999·15 cites·17 claims
- 2866US5587162ATreatment of allograft rejection with IL-2 receptor-specific cytotoxinsBETH ISRAEL HOSPITAL·Filed 1995·Granted Dec 24, 1996·16 cites·20 claims
- 2965US6113900AUse of IL-2 receptor-targeted therapeutics to inhibit allograft rejection and treat autoimmune disordersBETH ISRAEL HOSPITAL·Filed 1997·Granted Sep 5, 2000·8 cites·48 claims
- 3065US2005058624A1Chimeric IL-10 proteins and uses thereofBETH ISRAEL HOSPITAL·Filed 2004·Application pending·0 cites
- 3164US2007202125A1Inhibiting rejection of a graftBETH ISRAEL HOSPITAL ASS A MAS·Filed 2006·Application pending·0 cites
- 3262US2011020367A1Methods of Evaluating Transplant RejectionSTROM TERRY B·Filed 2009·Application pending·0 cites
- 3361US5571507AMethods of treating diabetesSERAGEN INC·Filed 1992·Granted Nov 5, 1996·23 cites·14 claims
- 3461US2007082356A1Methods of evaluating transplant rejectionBETH ISRAEL HOSPITAL·Filed 2006·Application pending·0 cites
- 3561US2005031611A1Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosisBETH ISRAEL HOSPITAL·Filed 2004·Application pending·0 cites
- 3660US10781248B2α1-antitrypsin compositions and methods of treating autoimmune diseasesBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Granted Sep 22, 2020·0 cites·12 claims
- 3760US2008089894A1Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosisSTROM TERRY B·Filed 2007·Application pending·0 cites
- 3860US2006246032A1Chimeric IL-10BETH ISRAEL HOSPITAL·Filed 2006·Application pending·0 cites
- 3958US2006057102A1Mutant interleukin-15-containing compositions and suppression of an immune responseZHENG XIN X·Filed 2005·Application pending·0 cites
- 4058US2015079085A1Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2014·Application pending·0 cites
- 4158US2013040301A1Methods of Evaluating Transplant RejectionCORNELL RES FOUNDATION INC·Filed 2012·Application pending·0 cites
- 4257US2003003098A1Inhibiting rejection of a graftBETH ISRAEL HOSPITAL ASS A MAS·Filed 2002·Application pending·0 cites
- 4357US2014147441A1Compositions containing alpha-1-antitrypsin and methods for useGEN HOSPITAL CORP·Filed 2013·Application pending·0 cites
- 4454US2013195895A1Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2013·Application pending·0 cites
- 4553US6281193B1Compounds that inhibit the binding of RAF-1 or 14-3-3 proteins to the beta chain of IL-2 receptor, and pharmaceutical compositions containing sameAPPLIED RESEARCH SYSTEMS·Filed 1997·Granted Aug 28, 2001·16 cites·2 claims
- 4651US2011020269A1Methods and compositions for modifying t cell immune responses and inflammationBETH ISRAEL HOSPITAL·Filed 2008·Application pending·0 cites
- 4750US2013183688A1Tim-3 ligands and methods thereofBRIGHAM & WOMENS HOSPITAL·Filed 2012·Application pending·0 cites
- 4850US2017065688A1Compositions containing alpha-1-antitrypsin and methods for useBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2016·Application pending·0 cites
- 4948US2006057680A1Mutant interleukin-15 polypeptidesZHENG XIN X·Filed 2005·Application pending·0 cites
- 5048US2011045002A1Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 functionBRIGHAM & WOMENS HOSPITAL·Filed 2010·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Terry B. Strom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →